아지노모토 바이오파마 서비스, 샌디에이고 무균 충전/완제 시설에서 32번째 의약품 품목 허가 획득 발표

Ajinomoto Bio-Pharma Services is thrilled to announce the approval of the 32nd drug product at our San Diego sterile fill finish site. Having supported 12 NDAs, 3 ANDAs, and 16 BLAs, we are making an impact on countless patient lives. In the past two years alone, we have contributed to 13 commercial drug product approvals. We are honored to be the CDMO that companies trust to fill their drug products from early clinical stages through to commercial success. Our ultimate goal is to provide responsive service, trusted partnership with our customers and deliver life-changing products to patients. We are proud to make a difference by improving the health of humankind. Together, we have the Power To Make.